Adriane Mosley

2.7k total citations
14 papers, 828 citations indexed

About

Adriane Mosley is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Adriane Mosley has authored 14 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Immunology. Recurrent topics in Adriane Mosley's work include Immune Cell Function and Interaction (4 papers), Pluripotent Stem Cells Research (3 papers) and CAR-T cell therapy research (3 papers). Adriane Mosley is often cited by papers focused on Immune Cell Function and Interaction (4 papers), Pluripotent Stem Cells Research (3 papers) and CAR-T cell therapy research (3 papers). Adriane Mosley collaborates with scholars based in United States, Germany and Sweden. Adriane Mosley's co-authors include Irving L. Weissman, Dean W. Felsher, Andrew S. Lee, Reza Ardehali, Micha Drukker, Chad Tang, Matthew A. Inlay, Renumathy Dhanasekaran, Divya Nag and Shawn L. Chavez and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Adriane Mosley

14 papers receiving 817 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adriane Mosley United States 9 607 156 155 151 124 14 828
Demirkan Gursel United States 19 491 0.8× 270 1.7× 112 0.7× 284 1.9× 125 1.0× 32 970
Eva Andreuzzi Italy 14 377 0.6× 155 1.0× 120 0.8× 160 1.1× 65 0.5× 25 671
Xavier Canron France 11 614 1.0× 285 1.8× 75 0.5× 136 0.9× 100 0.8× 12 879
Lucía Fanlo Spain 9 634 1.0× 309 2.0× 61 0.4× 214 1.4× 102 0.8× 10 919
Saswati Karmakar United States 12 467 0.8× 301 1.9× 127 0.8× 165 1.1× 55 0.4× 20 692
Saket Jain United States 18 455 0.7× 256 1.6× 195 1.3× 271 1.8× 67 0.5× 30 925
Jenny Paupert Belgium 15 311 0.5× 313 2.0× 81 0.5× 146 1.0× 89 0.7× 23 683
Nicolas Gengenbacher Germany 8 306 0.5× 194 1.2× 99 0.6× 153 1.0× 51 0.4× 10 629
Jeannine Diesch Australia 15 591 1.0× 155 1.0× 152 1.0× 152 1.0× 78 0.6× 20 852
Johannes von Burstin Germany 9 445 0.7× 368 2.4× 53 0.3× 129 0.9× 117 0.9× 13 741

Countries citing papers authored by Adriane Mosley

Since Specialization
Citations

This map shows the geographic impact of Adriane Mosley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adriane Mosley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adriane Mosley more than expected).

Fields of papers citing papers by Adriane Mosley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adriane Mosley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adriane Mosley. The network helps show where Adriane Mosley may publish in the future.

Co-authorship network of co-authors of Adriane Mosley

This figure shows the co-authorship network connecting the top 25 collaborators of Adriane Mosley. A scholar is included among the top collaborators of Adriane Mosley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adriane Mosley. Adriane Mosley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Deutzmann, Anja, Delaney K. Sullivan, Renumathy Dhanasekaran, et al.. (2024). Nuclear to cytoplasmic transport is a druggable dependency in MYC-driven hepatocellular carcinoma. Nature Communications. 15(1). 963–963. 8 indexed citations
2.
Krucinska, J., Adriane Mosley, Ivan Babić, et al.. (2024). Evaluation of UCP1162, a potent propargyl-linked inhibitor of dihydrofolate reductase with potential application to cancer and autoimmune disease. Biochemical Pharmacology. 230(Pt 3). 116617–116617. 1 indexed citations
3.
Wang, Zhichao, Khyatiben V. Pathak, Seema B. Plaisier, et al.. (2021). Metabolic convergence on lipogenesis in RAS, BCR-ABL, and MYC-driven lymphoid malignancies. SHILAP Revista de lepidopterología. 9(1). 31–31. 6 indexed citations
4.
Swaminathan, Srividya, Aida S. Hansen, Line Dam Heftdal, et al.. (2020). MYC functions as a switch for natural killer cell-mediated immune surveillance of lymphoid malignancies. Nature Communications. 11(1). 2860–2860. 51 indexed citations
5.
Gouw, Arvin M., Katherine Margulis, Anthony Mancuso, et al.. (2019). The MYC Oncogene Cooperates with Sterol-Regulated Element-Binding Protein to Regulate Lipogenesis Essential for Neoplastic Growth. Cell Metabolism. 30(3). 556–572.e5. 146 indexed citations
6.
Lai, Ian, Srividya Swaminathan, Virginie Baylot, et al.. (2018). Lipid nanoparticles that deliver IL-12 messenger RNA suppress tumorigenesis in MYC oncogene-driven hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer. 6(1). 125–125. 109 indexed citations
7.
Swaminathan, Srividya, Line Dam Heftdal, Renumathy Dhanasekaran, et al.. (2018). MYC Functions As a Master Switch for Natural Killer Cell-Mediated Immune Surveillance of Lymphoid Malignancies. Blood. 132(Supplement 1). 2619–2619. 1 indexed citations
8.
Mosley, Adriane, Felipe Vences‐Catalán, Narendiran Rajasekaran, et al.. (2017). Administration of low-dose combination anti-CTLA4, anti-CD137, and anti-OX40 into murine tumor or proximal to the tumor draining lymph node induces systemic tumor regression. Cancer Immunology Immunotherapy. 67(1). 47–60. 25 indexed citations
9.
Dhanasekaran, Renumathy, Virginie Baylot, Ian Lai, et al.. (2017). Anti-miR-17 therapy delays tumorigenesis in MYC-driven hepatocellular carcinoma (HCC). Oncotarget. 9(5). 5517–5528. 38 indexed citations
11.
Inlay, Matthew A., Thomas Serwold, Adriane Mosley, et al.. (2014). Identification of Multipotent Progenitors that Emerge Prior to Hematopoietic Stem Cells in Embryonic Development. Stem Cell Reports. 2(4). 457–472. 47 indexed citations
12.
Drukker, Micha, Chad Tang, Reza Ardehali, et al.. (2012). Isolation of primitive endoderm, mesoderm, vascular endothelial and trophoblast progenitors from human pluripotent stem cells. Nature Biotechnology. 30(6). 531–542. 87 indexed citations
13.
Parashurama, Natesh, Neethan A. Lobo, Ken Ito, et al.. (2012). Remodeling of Endogenous Mammary Epithelium by Breast Cancer Stem Cells. Stem Cells. 30(10). 2114–2127. 20 indexed citations
14.
Tang, Chad, Andrew S. Lee, Jens-Peter Volkmer, et al.. (2011). An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells. Nature Biotechnology. 29(9). 829–834. 286 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026